Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07469566
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of 7q11.23 microduplication confirmed by Chromosomal Microarray Analysis or qPCR.
* Aged \> 5 to \< 50 years
* Whose maternal language is French
* Having signed the informed consent and/or for whom parents/legal guardian have signed the informed consent.
* Affiliated to national Health Insurance system (sécurité sociale) or parents/legal guardian affiliated to national health insurance system Each 7DUP patient will be matched to a sex- and chronological age-matched control. Data from controls will come from the CREAT\_criteria study (NCT 06018519). Each 7DUP patient will be matched to a sex- and mental age-matched control. Data from controls will come from the CREAT\_criteria study (NCT 06018519).
Exclusion Criteria:
* Refusal of the subject and/or the subject's parents/legal guardian to sign the informed consent
* Refusal of the subject and/or the subject's parents/legal guardian to be informed of possible abnormalities detected during the neuropsychological assessment.
Regarding specifically the neuroimaging data (MRI):
* Having a contraindication to the MRI examination (people using a pacemaker or an insulin pump, people wearing a metal prosthesis or an intracerebral clip, and claustrophobic subjects).
* Refusal of the subject and/or the subject's parents/legal guardian to be informed of possible abnormalities detected by MRI.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
50 Years
Study:
NCT07469566
Study Brief:
Protocol Section:
NCT07469566